Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Yкраїнський (UK)
Przejdź do strony domowej biblioteki Centralna Biblioteka Wojskowa Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaCentralna Biblioteka Wojskowa

Wyszukujesz frazę "Angiogenesis" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-15 z 42
Tytuł:
GPU enhanced simulation of angiogenesis
Autorzy:
Worecki, M.
Wcisło, R.
Powiązania:
https://bibliotekanauki.pl/articles/305573.pdf
Data publikacji:
2012
Wydawca:
Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie. Wydawnictwo AGH
Tematy:
GPU
angiogenesis
tumor
Opis:
In the paper we present the use of graphic processor units to accelerate the most time-consuming stages of a simulation of angiogenesis and tumor growth. By the use of advanced CUDA mechanisms such as shared memory, textures and atomic operations, we managed to speed up the CUDA kernels by a factor of 57x. However, in our simulation we used the GPU as a co-processor and data from CPU was copied back and forth in each phase. It decreased the speedup of rewritten stages by 40%. We showed that the performance of the entire simulation can be improved by a factor of 10 up to 20.
Źródło:
Computer Science; 2012, 13 (1); 35-48
1508-2806
2300-7036
Pojawia się w:
Computer Science
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Cerebral angiogenesis after subarachnoid hemorrhage (SAH) and endothelin receptor blockage with BQ-123 antagonist in rats
Autorzy:
Josko, J.
Hendryk, S.
Jedrzejowska-Szypulka, H.
Slowinski, J.
Gwozdz, B.
Lange, D.
Snietura, M.
Zwirska-Korczala, K.
Jochem, J.
Powiązania:
https://bibliotekanauki.pl/articles/68985.pdf
Data publikacji:
2001
Wydawca:
Polskie Towarzystwo Fizjologiczne
Tematy:
endothelin receptor
angiogenesis
endothelin-1
blockade
rat
subarachnoid hemorrhage
cerebral angiogenesis
Źródło:
Journal of Physiology and Pharmacology; 2001, 52, 2
0867-5910
Pojawia się w:
Journal of Physiology and Pharmacology
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Czynnik wzrostu śródbłonka naczyń (VEGF) jako marker progresji choroby nowowotworowej - przegląd doniesień
Vascular endothelial growth factor (VEGF) as a marker for cancer progression - a review
Autorzy:
Flak, B.
Wawrzyniec, K.
Kwiatek, S.
Kawczyk-Krupka, A.
Czuba, Z.
Sieroń-Stołtny, K.
Sieroń, A.
Powiązania:
https://bibliotekanauki.pl/articles/261266.pdf
Data publikacji:
2013
Wydawca:
Politechnika Wrocławska. Wydział Podstawowych Problemów Techniki. Katedra Inżynierii Biomedycznej
Tematy:
angiogeneza
angiogeneza nowotworowa
przełączenie angiogenne
VEGF
hipoksja
angiogenesis
tumor angiogenesis
angiogenic switch
hypoxia
Opis:
Angiogeneza zwana również neowaskularyzacją jest wieloetapowym procesem tworzenia nowych naczyń krwionośnych w miejscu już istniejących, regulowanym przez czynniki pobudzające (proangiogenne) oraz hamujące (antyangiogenne). Nowotworzenie naczyń zachodzi w procesach fizjologicznych oraz w stanach patologicznych organizmu. W wyniku zaburzenia równowagi między czynnikami proangiogennymi, aktywującymi proces tworzenia nowych naczyń a czynnikami hamującymi (antyangiogennymi) dochodzi do przewagi aktywacji czynników angiogennych oraz nadmiernej angiogenezy, co sprzyja rozwojowi guza nowotworowego. W wyniku niedotlenienia (hipoksji) tkanki dochodzi do aktywacji czynników angiogennych, w tym przede wszystkim czynnika odgrywającego kluczową rolę w progresji nowotworowej – VEGF (ang. Vascular Endothelial Growth Factor). VEGF jest białkiem uważanym za główny czynnik odpowiedzialny za proces angiogenezy oraz wzrost przepuszczalności naczyń krwionośnych; nazywany jest również czynnikiem przepuszczalności naczyniowej. Najważniejszym czynnikiem indukującym proces angiogenezy oraz wydzielanie czynnika VEGF przez komórki nowotworowe jest niedotlenienie (hipoksja) panujące w mikrośrodowisku guza. VEGF jest złym czynnikiem prognostycznym odpowiadającym za progresję oraz aktywację tworzenia przerzutów wielu guzów litych. Zmniejszenie wydzielania czynnika VEGF ma istotne znaczenie w zahamowaniu procesu angiogenezy, a także potencjału metastatycznego komórek nowotworowych, które wcześniej nie uległy zniszczeniu na drodze apoptozy lub nekrozy.
Angiogenesis, also called neovascularization is a multistep process of forming new blood vessels and it is regulated by stimulating factors (proangiogenic) and inhibitors (anti-angiogenenic). Neovascularization occurs in physiological processes and in pathological states of the organism. As a result of an imbalance between proangiogenic factors activating the process of creating new blood vessels and inhibitors (anti-angiogenic) comes to lead the activation of angiogenic factors and excessive angiogenesis, which promotes tumor growth. As a result of hypoxia an activation of tissue angiogenic factors occurs, including, in particular, the key factor in tumor progression - VEGF (Vascular Endothelial Growth Factor). VEGF is a protein considered to be the main factor responsible for process of angiogenesis and an increased vascular permeability’ It is also known as a vascular permeability factor. The most important factor that induces angiogenesis and VEGF secretion by cancer cells is hypoxia in the tumor microenvironment. VEGF is a poor prognostic factor responsible for the progression and metastasis activation of many solid tumors. Decreased levels of VEGF is important in the inhibition of angiogenesis and metastatic potential of tumor cells that have not been destroyed by apoptosis or necrosis.
Źródło:
Acta Bio-Optica et Informatica Medica. Inżynieria Biomedyczna; 2013, 19, 4; 205-209
1234-5563
Pojawia się w:
Acta Bio-Optica et Informatica Medica. Inżynieria Biomedyczna
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Design of vascular endothelium-specific drug-targeting strategies for the treatment of cancer.
Autorzy:
Molema, Grietje
Powiązania:
https://bibliotekanauki.pl/articles/1041404.pdf
Data publikacji:
2005
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
angiogenesis
vascular drug-targeting
cancer
Opis:
Tumor endothelial cells are actively involved in the neovascularization processes that accompany tumor growth. Their easy accessibility for systemically applied therapeutics makes them interesting targets for therapeutic intervention. Especially for drug targeting-based therapeutics that often consist of macromolecular moieties, the tumor endothelium is considered a much better target than the tumor cells located behind the vascular wall barrier. In this review, the general principles underlying the development and choices in the development of vascular drug-targeting strategies are discussed. An overview of target epitopes identified in the past two decades is followed by a summary of those strategies that directly or indirectly induced tumor blood flow blockade in vivo. The demonstrated therapeutic success in pre-clinical animal models in debulking large tumor masses and inhibiting tumor outgrowth warrant further development of these therapeutic approaches. Yet, more effort should be put in studies in which the efficacy of different effector activities aimed at the same target, of one effector activity aimed at different targets, and of multiple target strategies are be compared. Combining these data with proper inventories on the molecular basis of tumor endothelial heterogeneity in general will make possible the development of tumor vascular drug-targeting strategies towards clinical application.
Źródło:
Acta Biochimica Polonica; 2005, 52, 2; 301-310
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Construction of a bicistronic proangiogenic expression vector and its application in experimental angiogenesis in vivo.
Autorzy:
Małecki;, Maciej
Przybyszewska, Małgorzata
Janik, Przemysław
Powiązania:
https://bibliotekanauki.pl/articles/1043468.pdf
Data publikacji:
2003
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
angiogenesis
gene therapy
bicistronic vectors
Opis:
Manipulation of angiogenesis in vivo is an example of successful gene therapy strategies. Overexpression of angiogenic genes like VEGF, FGF or PDGF causes new vessel formation and improves the clinical state of patients. Gene therapy is a very promising procedure but requires large amounts of pharmaceutical-grade plasmid DNA. In this regard we have constructed a bicistronic plasmid DNA vector encoding two proangiogenic factors, VEGF165 and FGF-2. The construct (pVIF) contains the internal ribosome entry site (IRES) of the encephalomyocarditis virus (ECMV) which permits both genes to be translated from a single bicistronic mRNA. The IRES sequence allows for a high efficiency of gene expression in vivo. The pVIF vector was characterized in vitro and in vivo. In vivo angiogenesis studies showed that the bicistronic vector encoding two proangiogenic factors induces the formation of new vessels significantly more than pVEGF165 or pFGF-2 alone. In our opinion the combined proangiogenic approach with VEGF165 and FGF-2 is more powerful and efficient than single gene therapy. We also postulate that IRES sequence can serve as a useful device improving efficiency of gene therapy.
Źródło:
Acta Biochimica Polonica; 2003, 50, 3; 875-882
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Pro-angiogenic effects of X-rays on murine endothelial cells
Autorzy:
Lisiak, E.
Dziekiewicz, M.
Meineke, V.
Bilski, M.
Janiak, M.
Powiązania:
https://bibliotekanauki.pl/articles/147804.pdf
Data publikacji:
2005
Wydawca:
Instytut Chemii i Techniki Jądrowej
Tematy:
angiogenesis
ionizing radiation
cell adhesion
integrins
Opis:
Recently, significant attention has been paid to the possibility of thwarting cancer progression by inhibition of neoangiogenesis (formation of new blood vessels) in growing tumors. Although general mechanisms of angiogenesis have been elucidated, virtually nothing is known about the effects of low doses of ionizing radiation on pro-angiogenic properties of endothelial cells. In the present study, we evaluated the effects of a low (0.2 Gy), intermediate (1 Gy), and high (4 Gy) doses of X-rays on a few angiogenesis-related parameters of isolated murine endothelial cells. We show here that 24 to 48 hours after irradiation with 0.2 Gy the cell proliferation was inhibited to a similar extent as after the exposure to 1 Gy. Also, adhesion of the 0.2 Gy-irradiated cells to both gelatin and MatrigelŽ was inhibited 24 hours post-exposure, whereas irradiation with 1 or 4 Gy resulted in the increased adhesion of the cells to these substrata. Similar effects were observed during the "wound" migration assay. Finally, 24 hours after exposure of the cells to 0.2 Gy of X-rays, the surface expression of the â3 integrin subunit was down-regulated, whereas irradiations with 1 and 4 Gy of X-rays resulted in the significantly elevated expression of this subunit. These results indicate that proliferating endothelial cells are sensitive in vitro to relatively low doses of ionizing radiation
Źródło:
Nukleonika; 2005, 50,suppl.2; 17-20
0029-5922
1508-5791
Pojawia się w:
Nukleonika
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Combination of vasostatin gene therapy with cyclophosphamide inhibits growth of B16(F10) melanoma tumours
Autorzy:
Jazowiecka-Rakus, Joanna
Jarosz, Magdalena
Szala, Stanisław
Powiązania:
https://bibliotekanauki.pl/articles/1041289.pdf
Data publikacji:
2006
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
angiogenesis
combination
vasostatin
cyclophosphamide
gene therapy
Opis:
Angiogenesis, i.e. formation of new blood vessels out of pre-existing capillaries, is essential to the development of tumour vasculature. The discovery of specific antiangiogenic inhibitors has important therapeutic implications for the development of novel cancer treatments. Vasostatin, the N-terminal domain of calreticulin, is a potent endogenous inhibitor of angiogenesis and tumour growth. In our study, using B16(F10) murine melanoma model and electroporation we attempted intramuscular transfer of human vasostatin gene. The gene therapy was combined with antiangiogenic drug dosing schedule of a known chemotherapeutic (cyclophosphamide). The combination of vasostatin gene therapy and cyclophosphamide administration improved therapeutic effects in melanoma tumours. We observed both significant inhibition of tumour growth and extended survival of treated mice. To our knowledge, this is one of the first reports showing antitumour efficacy of electroporation-mediated vasostatin gene therapy combined with antiangiogenic chemotherapy.
Źródło:
Acta Biochimica Polonica; 2006, 53, 1; 199-202
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Proangiogenic activity of plant extracts in accelerating wound healing - a new face of old phytomedicines
Autorzy:
Majewska, Iwona
Gendaszewska-Darmach, Edyta
Powiązania:
https://bibliotekanauki.pl/articles/1039823.pdf
Data publikacji:
2011
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
phytomedicines
angiogenesis
wound healing
plant extracts
Opis:
Angiogenesis, the formation of new capillaries from pre-existing vascular network, plays an important role in physiological and pathological processes such as embryonic development, wound healing, and development of atherosclerosis. Extension of the circulatory network is also considered to be one the most important factors during cancerogenesis. Inhibition of angiogenesis may lead to inhibition of tumor growth whereas stimulation may improve wound healing. Research achievements suggest the use of plants and their extracts as potential therapeutic agents with pro- or antiangiogenic activity. Since the anticancer and antiangiogenic properties of many phytomedicines have been amply reviewed elsewhere this paper will focus on the treatment of vascular insufficiency in wound healing. Globally accepted herbal drugs are thought to be safe and effective, however, there is a need for more evidence-based confirmation in controlled and validated trials. Among the most frequently studied proangiogenic phytochemicals are ginsenosides from Panax ginseng, beta-sitosterol from Aloe vera, calycosin from Radix Astragali, and extracts from Hippophae rhamnoides L. and Angelica sinensis.
Źródło:
Acta Biochimica Polonica; 2011, 58, 4; 449-460
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
MRI image analysis in patients with a tumor of the central nervous system : an attempt of developing a management algorithm
Analiza obrazu MRI u chorych z guzem ośrodkowego układu nerwowego : próba opracowania algorytmu postępowania
Autorzy:
Śniegocki, M.
Nowacka, A.
Fisz, J.
Śniegocka, A.
Buczkowski, M.
Powiązania:
https://bibliotekanauki.pl/articles/389840.pdf
Data publikacji:
2011
Wydawca:
Politechnika Bydgoska im. Jana i Jędrzeja Śniadeckich. Wydawnictwo PB
Tematy:
tumor
MRI image
angiogenesis
image analysis
Opis:
Magnetic resonance imaging study is currently the reference method for the detection and diagnosis of the central nervous system tumors. A large number of tumors, especially high-grade, has a higher water content in the cells, which results in prolongation of MRI T1 and T2 what appearance as increased signal intensity in in T2-weighted images and the reduction in T1-weighted images. MRI can be performed with administration of contrast agent, which shortens T1 and increases signal on T1-weighted sequences. This allows to identify areas of increased angiogenesis), which is the exponent of the cancer malignancy degree and its biological activity. Obtained MRI images are analyzed and evaluated by a radiologist and a clinician. Most of the time it is the "by the eye" analysis, which is based on the MRI image evaluation by the generally accepted radiological standards. However, this method is relatively inaccurate. which in turn can bring to the wrong diagnosis of the disease and implementation or even lack of implementation of appropriate treatment. More and more researches are conducted in this area, but developed methods are usually very complicated and difficult to carry out by the "layman" which is the clinician. That is why the attempt is made, to develop a simple and clear algorithm for MRI image analysis in patients with the central nervous system tumors, allowing for quick and objective evaluation of magnetic resonance imaging study.
Badanie metodą rezonansu magnetycznego jest aktualnie metodą referencyjną przy wykrywaniu i diagnozowaniu nowotworów centralnego układu nerwowego. Duża część nowotworów, zwłaszcza o wysokim stopniu złośliwości, charakteryzuje się większą zawartością wody w komórkach, co w badaniu MRI skutkuje wydłużeniem T1 i T2, uwidocznionym jako nasilenie sygnału w obrazach T2-zależnych oraz jego obniżeniem w obrazach T1-zależnych. MRI można przeprowadzić z podaniem środka kontrastowego, co powoduje skrócenie czasu T1 i podniesienie
Źródło:
Zeszyty Naukowe. Telekomunikacja i Elektronika / Uniwersytet Technologiczno-Przyrodniczy w Bydgoszczy; 2011, 15; 49-61
1899-0088
Pojawia się w:
Zeszyty Naukowe. Telekomunikacja i Elektronika / Uniwersytet Technologiczno-Przyrodniczy w Bydgoszczy
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Mathematical modelling of tumour angiogenesis
Autorzy:
Poleszczuk, Jan Tadeusz
Powiązania:
https://bibliotekanauki.pl/articles/748455.pdf
Data publikacji:
2013
Wydawca:
Polskie Towarzystwo Matematyczne
Tematy:
tumour angiogenesis
anti-angiogenic therapy
ODEs
Opis:
Mathematical models prove valuable tools to study the proof-of-concept and underlying mechanisms of a tumour progression. They enable us to explore possible radio-, chemo- and various therapy combinations that until now have been only a promising hypothesis because of huge costs of their clinical studies. Here we present a family of mathematical models of tumour angiogenesis, which were successfully compared to biological data. In addition, after modifications they can describe the effect of anti-angiogenic treatment for various vessels targeting agents, as well as the impact of cytotoxic agents on proliferating cancer cells. We present two ways in which the anti-angiogenic treatment cam be incorporated into the model. One describes the agents directly targeting tumour vessels, whereas the second focuses on agents interfering with angiogenic signalling. We illustrate differences between those two approaches by presenting fitting results to biological data.
Źródło:
Mathematica Applicanda; 2013, 41, 1
1730-2668
2299-4009
Pojawia się w:
Mathematica Applicanda
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Combined delivery of an antiangiogenic protein (angiostatin) and an immunomodulatory gene (interleukin-12) in the treatment of murine cancer.
Autorzy:
Wilczyńska, Urszula
Kucharska, Anna
Szary, Jarosław
Szala, Stanisław
Powiązania:
https://bibliotekanauki.pl/articles/1044050.pdf
Data publikacji:
2001
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
angiogenesis
IL-12 gene
tumor gene therapy
angiostatin
Opis:
We investigated the feasibility of a novel therapeutic approach to treat neoplastic diseases in mice. This novel strategy consists in delivering a protein (angiostatin) with strong antiangiogenic properties, followed by administration of the interleukin 12 gene that is strongly immunomodulatory and has also some antiangiogenic effects. When angiostatin-mediated antiangiogenic therapy was used in combination with intratumor delivery of the IL-12 gene (a strategy much safer than IL-12 protein administration), this produced a synergistic therapeutic effect.
Źródło:
Acta Biochimica Polonica; 2001, 48, 4; 1077-1084
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Singular controls and chattering arcs in optimal control problems arising in biomedicine
Autorzy:
Ledzewicz, U.
Schattler, H.
Powiązania:
https://bibliotekanauki.pl/articles/970774.pdf
Data publikacji:
2009
Wydawca:
Polska Akademia Nauk. Instytut Badań Systemowych PAN
Tematy:
optimal control
singular controls
biomedical models
anti-angiogenesis
Opis:
We consider an optimal control problem of the Mayer-type for a single-input, control affine, nonlinear system in small dimension. In this paper, we analyze effects that a modeling extension has on the optimality of singular controls when the control is replaced with the output of a first-order, time-invariant linear system driven by a new control. This analysis is motivated by an optimal control problem for a novel cancer treatment method, tumor anti-angiogenesis, when such a linear differential equation, which represents the pharmacokinetics of the therapeutic agent, is added to the model. We show that formulas that define a singular control of order 1 and its associated singular arc carry over verbatim under this model extension, albeit with a different interpretation. But the intrinsic order of the singular control increases to 2. As a, consequence, optimal concatenation sequences with the singular control change and the possibility of optimal chattering arcs arises.
Źródło:
Control and Cybernetics; 2009, 38, 4B; 1501-1523
0324-8569
Pojawia się w:
Control and Cybernetics
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Distinct inhibitory efficiency of siRNAs and DNAzymes to β1 integrin subunit in blocking tumor growth
Autorzy:
Wiktorska, Magdalena
Sacewicz-Hofman, Izabela
Stasikowska-Kanicka, Olga
Danilewicz, Marian
Niewiarowska, Jolanta
Powiązania:
https://bibliotekanauki.pl/articles/1039612.pdf
Data publikacji:
2013
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
adhesion
β1 integrins
invasiveness
tumor angiogenesis
tumor growth
Opis:
Receptors of the β1 integrin family are involved in many tumor-promoting activities. There are several approaches currently used to control integrin activity, and thus to potentially restrain tumor metastasis and angiogenesis. In this study, we compared inhibitory efficiencies of siRNA and DNAzymes against the β1 integrin subunit (DEβ1), in a mouse xenograft model. Both inhibitors were used under their most favorable conditions, in terms of concentrations, incubation time and lack of cytotoxic effects. Transfection of siRNAβ1 or DEβ1 remarkably inhibited the growth of both PC3 and HT29 colon cancer cells in vitro, and decreased their capability of initiating tumor formation in the mouse xenograft model. siRNAβ1 appeared to be slightly more efficient than DEβ1 when tested in vitro, however it was comparably less proficient in blocking the tumor growth in vivo. We conclude the DNAzyme, due to its greater resistance to degradation in extra- and intracellular compartments, to be a superior inhibitor of tumor growth in long lasting experiments in vivo when compared to siRNA, while the latter seems to be more efficient in blocking β1 expression during in vitro experiments using cell cultures.
Źródło:
Acta Biochimica Polonica; 2013, 60, 1; 77-82
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Carbon monoxide - a "new" gaseous modulator of gene expression.
Autorzy:
Dulak, Józef
Józkowicz, Alicja
Powiązania:
https://bibliotekanauki.pl/articles/1043644.pdf
Data publikacji:
2003
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
angiogenesis
vascular endothelial growth factor
atherosclerosis
nitric oxide
oxidative stress
Opis:
Carbon monoxide (CO) is an odorless, tasteless and colorless gas which is generated by heme oxygenase enzymes (HOs). HOs degrade heme releasing equimolar amounts of CO, iron and biliverdin, which is subsequently reduced to bilirubin. CO shares many properties with nitric oxide (NO), an established cellular messenger. Both CO and NO are involved in neural transmission and modulation of blood vessel function, including their relaxation and inhibition of platelet aggregation. CO, like NO, binds to heme proteins, although CO binds only ferrous (FeII) heme, whereas NO binds both ferrous and ferric (FeIII). CO enhances the activity of guanylate cyclase although it is less potent than NO. In contrast, CO inhibits other heme proteins, such as catalase or cytochrome P450. The effects of CO on gene expression can be thus varied, depending on the cellular microenvironment and the metabolic pathway being influenced. In this review the regulation of gene expression by HO/CO in the cardiovascular system is discussed. Recent data, derived also from our studies, indicate that HO/CO are significant modulators of inflammatory reactions, influencing the underlying processes such as cell proliferation and production of cytokines and growth factors.
Źródło:
Acta Biochimica Polonica; 2003, 50, 1; 31-47
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Ekspresja czynnika VEGF i receptora R1 w mięśniakach macicy kobiet w różnym wieku
Expression of VEGF factor and R1 receptor in uterine myomas in women of different age
Autorzy:
Bogunia, Edyta
Morek, Michał
Plewka, Andrzej
Plewka, Danuta
Miśkiewicz, Adam
Wittek, Piotr
Kurpas, Piotr
Bilski, Rafał
Madej, Paweł
Powiązania:
https://bibliotekanauki.pl/articles/1038090.pdf
Data publikacji:
2013
Wydawca:
Śląski Uniwersytet Medyczny w Katowicach
Tematy:
angiogeneza
mięśniaki
kobieta
vegf
vegf-r1
angiogenesis
myoma
woman
Opis:
Uterine myomas are the most common benign neoplasms of female reproductive organs. These neoplasms depend upon the impact of steroidal sex hormones – estrogen and progesterone. In uterine myoma cells a disturbed expression of some cytokines and factors is found, including angiogenic factors. The aim of the study was to evaluate the VEGF factor and VEGF-R1 receptor expression in uterine myomas. In the study there were 20 women with myomatous alterations in the uterus, including 10 women in reproductive age and 10 women in perimenopausal age. The study material consisted of tissue specimens taken from the myoma and specimens taken from normal myometrium. Evaluation of the VEGF factor and R1 receptor expression was conducted by means of immunohistochemical staining, using the ABC technique. In the evaluated cells with uterine myoma, both in young women and those in perimenopausal age, a significant increase in VEGF expression was found. This expression was independent of the myoma size. Moreover, a significantly higher VEGF-R1 expression was found in large myomas compared to small ones. The high VEGF factor expression level in women in perimenopausal age may indicate an additional local process of estrogen synthesis. The high VEGF-R1 expression in large myomas may suggest a direct stimulation of myoma growth affected by VEGF.
Mięśniaki macicy należą do najczęstszych łagodnych nowotworów żeńskich narządów płciowych. Są to nowotwory zależne od wpływu steroidowych hormonów płciowych – estrogenów i progesteronu. W komórkach mięśniaków macicy stwierdza się zaburzoną ekspresję niektórych cytokin i czynników, w tym czynników angiogennych. Celem badań była ocena ekspresji naczyniowo-śródbłonkowego czynnika wzrostu VEGF (vascular endothelial growth factor) i receptora VEGF-R1 (vascular endothelial growth factor receptor 1) w mięśniakach macicy. Badaniem objęto 20 kobiet ze zmianami mięśniakowatymi w macicy, w tym 10 w wieku rozrodczym i 10 w wieku okołomenopauzalnym. Materiał do badań stanowiły wycinki tkankowe pobrane z mięśniaka oraz próbki pobrane z prawidłowego miometrium. Ekspresję czynnika VEGF i receptora R1 oceniano na podstawie barwienia immunohistochemicznego, wykorzystując technikę ABC. W ocenianych typach komórek macicy z mięśniakami, zarówno u kobiet młodych, jak i w wieku okołomenopauzalnym stwierdzono wyraźny wzrost ekspresji VEGF. Ekspresja ta była niezależna od wielkości mięśniaka. Stwierdzono także wyraźnie wyższą ekspresję VEGF-R1 w mięśniakach dużych niż w małych. Wysoki poziom ekspresji czynnika VEGF u kobiet w wieku okołomenopauzalnym może wskazywać na dodatkowy lokalny proces syntezy estrogenów. Wysoka ekspresja VEGF-R1 w mięśniakach dużych może świadczyć
Źródło:
Annales Academiae Medicae Silesiensis; 2013, 67, 5; 303-310
1734-025X
Pojawia się w:
Annales Academiae Medicae Silesiensis
Dostawca treści:
Biblioteka Nauki
Artykuł
Wyświetlanie 1-15 z 42

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies